<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02010515</url>
  </required_header>
  <id_info>
    <org_study_id>UMG-181211</org_study_id>
    <nct_id>NCT02010515</nct_id>
  </id_info>
  <brief_title>An Arrhythmia Risk Predictor Trial</brief_title>
  <official_title>Clinical-Electrophysiological Risk Marker Trial Goettingen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective single-center study is an observational risk stratification trial in about
      250 patients with standard indications for ICD treatment.

      Implantable cardioverter defibrillators (ICD) have been shown to improve survival and current
      guidelines recommend their use for primary and secondary prevention of sudden cardiac death
      (SCD). However, a large number of patients never receive an appropriate therapy from their
      device. In contrast, electrical sorm and multiple ICD shocks occur in other patients.

      Thus, identification of predictors for survival or ICD shocks is necessary for improved
      patient selection and optimized therapeutic strategies.

      Risk stratification with electrocardiogram (ECG) and signal averaged ECG (SAECG), T-wave
      alternans (TWA) and Holter ECG including premature ventricular contractions (PVC),
      non-sustained VT (nsVT), heart rate variability (HRV), heart rate turbulence (HRT) and
      deceleration capacity, as well as clinical variables is possible, but not implemented in
      clinical routine in patients with ischemic or dilated cardiomyopathy and newly implanted ICD
      for primary or secondary prevention of SCD following current guidelines.

      Patients will be prospectively followed and the predictive value of the risk markers
      mentioned above to predict all-cause mortality or appropriate ICD shocks will be
      investigated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-Cause Mortality</measure>
    <time_frame>2008-2013</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>First Appropriate ICD Shock</measure>
    <time_frame>2008-2013</time_frame>
    <description>First ICD discharge for malignant ventricular arrhythmia</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">282</enrollment>
  <condition>Cardiomyopathy</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Sinus rhythm, first ICD implantation</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with ischemic or dilated cardiomyopathy and &quot;standard indications&quot; for ICD
        treatment. &quot;Stamdard indications&quot; are approved and strictly follow current guidelines, the
        decision on ICD implantation is based on left-ventricular ejection fraction or the history
        of malignant arrhythmia. i.e. secondary prevention of sudden cardiac death). Implantation
        procedure is performed at University Medical Center Goettingen.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ischemic or dilated cardiomyopathy

          -  sinusrhythm

          -  ICD indication strictly following current guidelines (primary and secondary prevention
             of SCD)

          -  Age 18 years or older

        Exclusion Criteria:

          -  no consent

          -  atrial fibrillation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Zabel, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Goettingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Goettingen</name>
      <address>
        <city>Goettingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL; American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Sep 5;114(10):e385-484. Epub 2006 Aug 25.</citation>
    <PMID>16935995</PMID>
  </reference>
  <reference>
    <citation>Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058. Review.</citation>
    <PMID>18804736</PMID>
  </reference>
  <reference>
    <citation>Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN; MUSTT Investigators. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007 Sep 18;50(12):1150-7. Epub 2007 Sep 4.</citation>
    <PMID>17868806</PMID>
  </reference>
  <reference>
    <citation>Hohnloser SH, Ikeda T, Bloomfield DM, Dabbous OH, Cohen RJ. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet. 2003 Jul 12;362(9378):125-6.</citation>
    <PMID>12867114</PMID>
  </reference>
  <reference>
    <citation>Buckingham TA, Thessen CC, Stevens LL, Redd RM, Kennedy HL. Effect of conduction defects on the signal-averaged electrocardiographic determination of late potentials. Am J Cardiol. 1988 Jun 1;61(15):1265-71.</citation>
    <PMID>3376884</PMID>
  </reference>
  <reference>
    <citation>Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984 Feb;69(2):250-8.</citation>
    <PMID>6690098</PMID>
  </reference>
  <reference>
    <citation>Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schömig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999 Apr 24;353(9162):1390-6.</citation>
    <PMID>10227219</PMID>
  </reference>
  <reference>
    <citation>Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, Hnatkova K, Schömig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006 May 20;367(9523):1674-81.</citation>
    <PMID>16714188</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2013</study_first_submitted>
  <study_first_submitted_qc>December 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2013</study_first_posted>
  <last_update_submitted>December 9, 2013</last_update_submitted>
  <last_update_submitted_qc>December 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Markus Zabel</investigator_full_name>
    <investigator_title>Associate Professor, Head of Clinical Electrophysiology</investigator_title>
  </responsible_party>
  <keyword>sudden cardiac death</keyword>
  <keyword>risk stratification</keyword>
  <keyword>t-wave alternans</keyword>
  <keyword>Holter electrocardiography</keyword>
  <keyword>heart rate turbulence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

